Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (6), 929-935
- https://doi.org/10.1016/j.jacc.2003.11.028
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial FibrillationCirculation, 2002
- ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summaryJournal of the American College of Cardiology, 2001
- Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial FibrillationCirculation, 2000
- Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial FibrillationStroke, 2000
- Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial FibrillationStroke, 1999
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation studyJournal Of Stroke & Cerebrovascular Diseases, 1995
- Oral Anticoagulants and Intracranial HemorrhageStroke, 1995